AAAAAA

   
Results: 1-15 |
Results: 15
TREATMENT OF UTERINE FIBROIDS WITH A SLOW-RELEASE FORMULATION OF THE GONADOTROPIN-RELEASING-HORMONE ANTAGONIST CETRORELIX
Authors: FELBERBAUM RE GERMER U LUDWIG M RIETHMULLERWINZEN H HEISE S BUTTGE I BAUER O REISSMANN T ENGEL J DIEDRICH K
Citation: Re. Felberbaum et al., TREATMENT OF UTERINE FIBROIDS WITH A SLOW-RELEASE FORMULATION OF THE GONADOTROPIN-RELEASING-HORMONE ANTAGONIST CETRORELIX, Human reproduction (Oxford. Print), 13(6), 1998, pp. 1660-1668
PLASMA AND FOLLICULAR-FLUID CONCENTRATIONS OF GNRH ANTAGONIST CETRORELIX AFTER MULTIPLE APPLICATION OF DIFFERENT DOSES FOR THE HORMONAL-STIMULATION IN IVF CYCLES
Authors: LUDWIG M FELBERBAUM R ALBANO C SMITZ J ORTMANN O RIETHMULLERWINZEN H DEVROEY P DIEDRICH K
Citation: M. Ludwig et al., PLASMA AND FOLLICULAR-FLUID CONCENTRATIONS OF GNRH ANTAGONIST CETRORELIX AFTER MULTIPLE APPLICATION OF DIFFERENT DOSES FOR THE HORMONAL-STIMULATION IN IVF CYCLES, Human reproduction (Oxford. Print), 13, 1998, pp. 76-76
MAINTAINED LOW ESTRADIOL SECRETION DURING LONG-TERM GNRH ANTAGONIST TREATMENT
Authors: FELBERBAUM R KUPKER W RIETHMULLERWINZEN H DIEDRICH K
Citation: R. Felberbaum et al., MAINTAINED LOW ESTRADIOL SECRETION DURING LONG-TERM GNRH ANTAGONIST TREATMENT, Human reproduction (Oxford. Print), 13, 1998, pp. 199-199
THE LUTEAL-PHASE OF NONSUPPLEMENTED CYCLES AFTER OVARIAN SUPEROVULATION WITH HUMAN MENOPAUSAL GONADOTROPIN AND THE GONADOTROPIN-RELEASING-HORMONE ANTAGONIST CETVORELIX
Authors: ALBANO C GRIMBIZIS G SMITZ J RIETHMULLERWINZEN H REISSMANN T VANSTEIRTEGHEM A DEVROEY P
Citation: C. Albano et al., THE LUTEAL-PHASE OF NONSUPPLEMENTED CYCLES AFTER OVARIAN SUPEROVULATION WITH HUMAN MENOPAUSAL GONADOTROPIN AND THE GONADOTROPIN-RELEASING-HORMONE ANTAGONIST CETVORELIX, Fertility and sterility, 70(2), 1998, pp. 357-359
PK-PD MODELING OF CETRORELIX EFFECTS ON CIRCADIAN TESTOSTERONE PRODUCTION
Authors: DERENDORF H HERMANN R ROMEIS P LOCHER M SCHNAARS Y RIETHMULLERWINZEN H
Citation: H. Derendorf et al., PK-PD MODELING OF CETRORELIX EFFECTS ON CIRCADIAN TESTOSTERONE PRODUCTION, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 76-76
TREATMENT OF UTERINE LEIOMYOMAS WITH LUTEINIZING-HORMONE-RELEASING HORMONE ANTAGONIST CETRORELIX
Authors: GONZALEZBARCENA D ALVAREZ RB OCHOA EP CORNEJO IC COMARUSCHALLY AM SCHALLY AV ENGEL J REISSMANN T RIETHMULLERWINZEN H
Citation: D. Gonzalezbarcena et al., TREATMENT OF UTERINE LEIOMYOMAS WITH LUTEINIZING-HORMONE-RELEASING HORMONE ANTAGONIST CETRORELIX, Human reproduction, 12(9), 1997, pp. 2028-2035
MULTIPLE-DOSE APPLICATIONS OF THE LHRH-ANTAGONIST CETRORELIX(SB-75) IN ASSISTED REPRODUCTION ACCORDING TO THE LUBECK-PROTOCOL - THE FIRST STEPS
Authors: FELBERBAUM R REISSMANN T ROMEIS P RIETHMULLERWINZEN H DIEDRICH C DIEDRICH K
Citation: R. Felberbaum et al., MULTIPLE-DOSE APPLICATIONS OF THE LHRH-ANTAGONIST CETRORELIX(SB-75) IN ASSISTED REPRODUCTION ACCORDING TO THE LUBECK-PROTOCOL - THE FIRST STEPS, Human reproduction, 12, 1997, pp. 124-124
SERUM AND FOLLICULAR-FLUID CETRORELIX CONCENTRATIONS IN OVARIAN STIMULATION CYCLES
Authors: ALBANO C SMITZ J CAMUS M RIETHMULLERWINZEN H SIEBERTWELGEL M ROMELS P VANSTEIRTEGHEM A DEVROEY P
Citation: C. Albano et al., SERUM AND FOLLICULAR-FLUID CETRORELIX CONCENTRATIONS IN OVARIAN STIMULATION CYCLES, Human reproduction, 12, 1997, pp. 215-215
COMPARISON OF DIFFERENT DOSES OF GONADOTROPIN-RELEASING-HORMONE ANTAGONIST CETRORELIX DURING CONTROLLED OVARIAN HYPERSTIMULATION
Authors: ALBANO C SMITZ J CAMUS M RIETHMULLERWINZEN H VANSTEIRTEGHEM A DEVROEY P
Citation: C. Albano et al., COMPARISON OF DIFFERENT DOSES OF GONADOTROPIN-RELEASING-HORMONE ANTAGONIST CETRORELIX DURING CONTROLLED OVARIAN HYPERSTIMULATION, Fertility and sterility, 67(5), 1997, pp. 917-922
ENANTIOSELECTIVE PHARMACOKINETICS AND BIOAVAILABILITY OF DIFFERENT RACEMIC ALPHA-LIPOIC ACID FORMULATIONS IN HEALTHY-VOLUNTEERS
Authors: HERMANN R NIEBCH G BORBE HO FIEGERBUSCHGES H RUUS P NOWAK H RIETHMULLERWINZEN H PEUKERT M BLUME H
Citation: R. Hermann et al., ENANTIOSELECTIVE PHARMACOKINETICS AND BIOAVAILABILITY OF DIFFERENT RACEMIC ALPHA-LIPOIC ACID FORMULATIONS IN HEALTHY-VOLUNTEERS, European journal of pharmaceutical sciences, 4(3), 1996, pp. 167-174
SUBTLE PROGESTERONE RISE AFTER THE ADMINISTRATION OF THE GONADOTROPIN-RELEASING-HORMONE ANTAGONIST CETRORELIX IN INTRACYTOPLASMIC SPERM INJECTION CYCLES
Authors: UBALDI F ALBANO C PEUKERT M RIETHMULLERWINZEN H CAMUS M SMITZ J VANSTEIRTEGHEM A DEVROEY P
Citation: F. Ubaldi et al., SUBTLE PROGESTERONE RISE AFTER THE ADMINISTRATION OF THE GONADOTROPIN-RELEASING-HORMONE ANTAGONIST CETRORELIX IN INTRACYTOPLASMIC SPERM INJECTION CYCLES, Human reproduction, 11(7), 1996, pp. 1405-1407
HORMONAL PROFILE DURING THE FOLLICULAR PHASE IN CYCLES STIMULATED WITH A COMBINATION OF HUMAN MENOPAUSAL GONADOTROPIN AND GONADOTROPIN-RELEASING-HORMONE ANTAGONIST (CETRORELIX)
Authors: ALBANO C SMITZ J CAMUS M RIETHMULLERWINZEN H SIEBERTWEIGEL M DIEDRICH K VANSTEIRTEGHEM AC DEVROEY P
Citation: C. Albano et al., HORMONAL PROFILE DURING THE FOLLICULAR PHASE IN CYCLES STIMULATED WITH A COMBINATION OF HUMAN MENOPAUSAL GONADOTROPIN AND GONADOTROPIN-RELEASING-HORMONE ANTAGONIST (CETRORELIX), Human reproduction, 11(10), 1996, pp. 2114-2118
TOLERABILITY AND PHARMACOKINETICS OF SINGLE AND MULTIPLE DOSES OF AZELASTINE HYDROCHLORIDE IN ELDERLY VOLUNTEERS
Authors: PETER G ROMEIS P BORBE HO BUKER KM RIETHMULLERWINZEN H
Citation: G. Peter et al., TOLERABILITY AND PHARMACOKINETICS OF SINGLE AND MULTIPLE DOSES OF AZELASTINE HYDROCHLORIDE IN ELDERLY VOLUNTEERS, Arzneimittel-Forschung, 45(5), 1995, pp. 576-581
TOLERABILITY, PHARMACOKINETICS AND DOSE LINEARITY OF AZELASTINE HYDROCHLORIDE IN HEALTHY-SUBJECTS
Authors: RIETHMULLERWINZEN H PETER G BUKER KM ROMEIS P BORBE HO
Citation: H. Riethmullerwinzen et al., TOLERABILITY, PHARMACOKINETICS AND DOSE LINEARITY OF AZELASTINE HYDROCHLORIDE IN HEALTHY-SUBJECTS, Arzneimittel-Forschung, 44-2(10), 1994, pp. 1136-1140
TOLERABILITY, PHARMACOKINETICS AND DOSE LINEARITY OF AZELASTINE HYDROCHLORIDE IN HEALTHY-SUBJECTS
Authors: RIETHMULLERWINZEN H PETER G BUKER KM ROMEIS P BORBE HO
Citation: H. Riethmullerwinzen et al., TOLERABILITY, PHARMACOKINETICS AND DOSE LINEARITY OF AZELASTINE HYDROCHLORIDE IN HEALTHY-SUBJECTS, Arzneimittel-Forschung, 44-2(10), 1994, pp. 1136-1140
Risultati: 1-15 |